These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

333 related items for PubMed ID: 16162746

  • 1. Anticoagulant therapy for idiopathic pulmonary fibrosis.
    Kubo H, Nakayama K, Yanai M, Suzuki T, Yamaya M, Watanabe M, Sasaki H.
    Chest; 2005 Sep; 128(3):1475-82. PubMed ID: 16162746
    [Abstract] [Full Text] [Related]

  • 2. [Anticoagulant therapy for idiopathic pulmonary fibrosis].
    Kubo H.
    Rev Port Pneumol; 2005 Sep; 11(6):591-2. PubMed ID: 16521238
    [No Abstract] [Full Text] [Related]

  • 3. [Outcome of patients with acute exacerbation of idiopathic interstitial fibrosis (IPF) treated with sivelestat and the prognostic value of serum KL-6 and surfactant protein D].
    Nakamura M, Ogura T, Miyazawa N, Tagawa A, Kozawa S, Watanuki Y, Takahashi H.
    Nihon Kokyuki Gakkai Zasshi; 2007 Jun; 45(6):455-9. PubMed ID: 17644940
    [Abstract] [Full Text] [Related]

  • 4. Unfavourable effects of medically indicated oral anticoagulants on survival in idiopathic pulmonary fibrosis.
    Kreuter M, Wijsenbeek MS, Vasakova M, Spagnolo P, Kolb M, Costabel U, Weycker D, Kirchgaessler KU, Maher TM.
    Eur Respir J; 2016 Jun; 47(6):1776-84. PubMed ID: 27103382
    [Abstract] [Full Text] [Related]

  • 5. The effect of anticoagulant therapy for idiopathic pulmonary fibrosis in real life practice.
    Tomassetti S, Ruy JH, Gurioli C, Ravaglia C, Buccioli M, Tantalocco P, Decker PA, Cavazza A, Dubini A, Agnoletti V, Gurioli C, Casoni GL, Romagnoli M, Poletti V.
    Sarcoidosis Vasc Diffuse Lung Dis; 2013 Aug 01; 30(2):121-7. PubMed ID: 24071883
    [Abstract] [Full Text] [Related]

  • 6. High D-dimer levels predict cardiovascular events in patients with chronic atrial fibrillation during oral anticoagulant therapy.
    Vene N, Mavri A, Kosmelj K, Stegnar M.
    Thromb Haemost; 2003 Dec 01; 90(6):1163-72. PubMed ID: 14652652
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Thrombomodulin for acute exacerbations of idiopathic pulmonary fibrosis: a proof of concept study.
    Tsushima K, Yamaguchi K, Kono Y, Yokoyama T, Kubo K, Matsumura T, Ichimura Y, Abe M, Terada J, Tatsumi K.
    Pulm Pharmacol Ther; 2014 Dec 01; 29(2):233-40. PubMed ID: 24836398
    [Abstract] [Full Text] [Related]

  • 11. [Effects of anticoagulant therapy for rapidly progressive interstitial pneumonias].
    Watanabe K, Tajima S, Tanaka J, Moriyama H, Nakayama H, Terada M, Takada T, Suzuki E, Narita I.
    Nihon Kokyuki Gakkai Zasshi; 2011 Jun 01; 49(6):407-12. PubMed ID: 21735740
    [Abstract] [Full Text] [Related]

  • 12. Serum analysis of coagulation factors in IPF and NSIP.
    Bargagli E, Madioni C, Bianchi N, Refini RM, Cappelli R, Rottoli P.
    Inflammation; 2014 Feb 01; 37(1):10-6. PubMed ID: 23912648
    [Abstract] [Full Text] [Related]

  • 13. D-dimer as a prognostic biomarker for mortality in chronic obstructive pulmonary disease exacerbation.
    Fruchter O, Yigla M, Kramer MR.
    Am J Med Sci; 2015 Jan 01; 349(1):29-35. PubMed ID: 25233043
    [Abstract] [Full Text] [Related]

  • 14. Cyclophosphamide and low-dose prednisolone in idiopathic pulmonary fibrosis and fibrosing nonspecific interstitial pneumonia.
    Kondoh Y, Taniguchi H, Yokoi T, Nishiyama O, Ohishi T, Kato T, Suzuki K, Suzuki R.
    Eur Respir J; 2005 Mar 01; 25(3):528-33. PubMed ID: 15738299
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Clinical analysis of the acute exacerbation in patients with idiopathic pulmonary fibrosis].
    Okamoto T, Ichiyasu H, Ichikado K, Muranaka H, Sato K, Okamoto S, Iyonaga K, Suga M, Kohrogi H.
    Nihon Kokyuki Gakkai Zasshi; 2006 May 01; 44(5):359-67. PubMed ID: 16780093
    [Abstract] [Full Text] [Related]

  • 17. [Evaluation of D-dimer in outpatients: clinical value and specific features].
    Vavilova TV, Vorob'eva IuK, Krupotkina IG, Mnuskina MM, Zherlitsina EA, Minkin SR.
    Klin Lab Diagn; 2009 Nov 01; (11):42-6. PubMed ID: 20050285
    [Abstract] [Full Text] [Related]

  • 18. [Coagulopathy correlates with outcomes in patients with community- acquired pneumonia].
    Zhuang Q, Zeng Y, Shi Y.
    Zhonghua Jie He He Hu Xi Za Zhi; 2014 Jun 01; 37(6):406-10. PubMed ID: 25200038
    [Abstract] [Full Text] [Related]

  • 19. Possible Serological Markers to Predict Mortality in Acute Exacerbation of Idiopathic Pulmonary Fibrosis.
    Hachisu Y, Murata K, Takei K, Tsuchiya T, Tsurumaki H, Koga Y, Horie T, Takise A, Hisada T.
    Medicina (Kaunas); 2019 May 13; 55(5):. PubMed ID: 31086028
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.